04 August 2022
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
Penny McCormick, Chief Executive Officer
via Walbrook PR
SPARK Advisory Partners Limited (NOMAD)
Tel: +44 (0)20 3368 3550
Oberon Capital Ltd (Broker)
Tel: +44 (0)20 3179 5344
Walbrook PR Ltd (Media & IR)
Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus / Alice Woodings
Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
Details of the person discharging managerial responsibilities / person closely associated
Reason for the notification
Initial notification /Amendment
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
Nature of the transaction
Purchase of Ordinary Shares
Price(s) and volume(s)
- Aggregated volume
N/A - Single Transaction
Date of the transaction
3 August 2022
Place of the transaction
London Stock Exchange - AIMX